文献速递介入腹部DSA

高危不良事件患者经皮肝穿刺胆道引流:三级转诊中心经验

Percutaneous transhepatic biliary drainage in patients at higher risk for adverse events: experience from a tertiary care referral center.
PubMed 文献 · Abdom Radiol (NY) · 2020-01-01

回顾性分析2017年11月至2019年4月连续90例经皮肝穿刺胆道引流(PTBD),其中57例(63.3%)存在至少一项不良事件高危因素(非扩张胆管、中等量肝周积液、凝血功能障碍、意识改变、床旁操作)。该高危组技术成功率91.2%,主要并发症胆性腹膜炎3例(5.2%),无操作相关死亡。作者结论认为即使存在这些高危条件,PTBD仍可有效安全实施,不应仅因存在这些条件而拒绝PTBD。

要点

  • 高危因素以非扩张胆管系统最常见(32例,56.1%),其次为肝周积液和凝血参数异常(各9例,15.8%)。
  • 高危患者PTBD总体技术成功率91.2%(52例),主要并发症胆性腹膜炎3例(5.2%),无操作相关死亡。
  • 作者认为不应仅因存在高危条件而拒绝PTBD。

核心结论

  • 作者结论认为,即使存在被认为增加不良事件风险的条件,PTBD仍可有效且安全地实施,因此不应仅因存在这些条件而拒绝PTBD。

研究设计与样本

  • 回顾性研究,纳入2017年11月至2019年4月连续90例PTBD患者,来自单中心介入放射科;高危患者定义为具有以下一项或多项因素:非扩张胆管系统、中等量肝周积液、凝血功能障碍、意识改变、床旁操作;记录技术成功、并发症及3个月结局。

诊断标准与关键数值

  • 高危患者57例(63.3%,平均年龄47.6岁,女性35例),其中左侧PTBD 37例(64.9%)、右侧15例(26.3%)、双侧3例(5.2%)、经皮胆囊造瘘途径2例(3.5%);总体技术成功率91.2%(52例);主要并发症胆性腹膜炎3例(5.2%);无操作相关死亡;高危因素分布:非扩张胆管系统32例(56.1%)、肝周积液9例(15.8%)、凝血参数异常9例(15.8%)、ICU床旁操作5例(8.8%)、意识改变2例(3.5%)。

临床应用与阅片要点

  • 作者结论认为PTBD在高危患者中可有效且安全实施,不应仅因存在这些条件而拒绝PTBD。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Despite advances in endoscopic drainage procedures, percutaneous transhepatic biliary drainage (PTBD) remains an essential interventional radiology (IR) procedure. Several factors may adversely affect the success of PTBD. We report the experience of our IR unit with PTBD in patients considered at higher risk for adverse events.

MATERIAL: Consecutive PTBDs performed between November 2017 and April 2019 were retrospectively reviewed. The patients at increased risk for adverse events from PTBD, defined by one or more of the following factors: non-dilated system, moderate amount of perihepatic fluid, coagulopathy, altered sensorium, and PTBD performed at bedside, were identified. Technical success, complications, and outcome at 3 months were recorded.

RESULTS: During the study period, PTBDs were performed in 90 patients. PTBDs in 57 (63.3%) patients (mean age 47.6 years, 35 females) were identified as predisposing to higher risk for adverse events. Left and right PTBD were performed in 37 (64.9%) and 15 (26.3%) patients, respectively. Bilateral PTBDs were performed in three (5.2%) patients. In two (3.5%) cases, biliary access was obtained via percutaneous cholecystostomy. Overall technical success of 91.2% (n = 52) was achieved. Carcinoma gallbladder was the most common underlying cause. Non-dilated ductal system was the most common condition deemed to predispose to higher risk for adverse events (n = 32, 56.1%), followed by perihepatic fluid (n = 9, 15.8%), and deranged coagulation parameters (n = 9, 15.8%). PTBD was performed at bedside in intensive care unit in 5 (8.8%) patients. Two (3.5%) patients had altered sensorium. Major complications in the form of biliary peritonitis were observed in three (5.2%) patients. No procedure-related mortality was observed.

CONCLUSION: PTBD can be effectively and safely performed even in situations deemed to predispose patients to increased risk for adverse events. Thus, the mere presence of these conditions should not cause a denial of PTBD.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Gupta P, Maralakunte M, Rathee S, et al. Percutaneous transhepatic biliary drainage in patients at higher risk for adverse events: experience from a tertiary care referral center. Abdom Radiol (NY). 2020. PMID: 31776603. doi:10.1007/s00261-019-02344-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。